Track Sintx Technologies, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Sintx Technologies, Inc. SINT · Stock Open Sintx Technologies, Inc. in new tab

1.35 USD
EPS
-1.54
P/B
2.73
ROE
-250.39
Beta
0.57
Target Price
9.25 USD
Loading chart...
Key Metrics
Earnings dateMarch 19, 2027
EPS-1.54
Book Value0.49
Price to Book2.73
Debt/Equity88.61
% Insiders26.922%
Growth
Revenue Growth9.53%
Estimates
Forward P/E-1.26
Forward EPS-1.06
Target Mean Price9.25

DCF valuation

Model fair value for Sintx Technologies, Inc. (SINT)
Result
Sign in to run the valuation for SINT.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
4 analysts · consensus Strong buy · mean target 9.25 USD (low 6.00, high 12.50) · as of 15 Nov 2026
Low 6.00
Mean 9.25
High 12.50
Price 1.35
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Sintx Technologies, Inc. Logo Sintx Technologies, Inc. Analysis (SINT)

United States Health Care Official Website Stock

Is Sintx Technologies, Inc. a good investment? Sintx Technologies, Inc. (SINT) is currently trading at 1.35 USD. Market analysts have a consensus price target of 9.25 USD. This suggests a potential upside from current levels.

Earnings Schedule: Sintx Technologies, Inc. is expected to release its next earnings report on March 19, 2027. The market consensus estimate for Forward EPS is -1.06.

Investor FAQ

Does Sintx Technologies, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Sintx Technologies, Inc.?

Sintx Technologies, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be March 19, 2027. The company currently has a trailing EPS of -1.54.

Company Profile

Sintx Technologies, Inc., an advanced ceramics and biomaterials company, engages in the research, development, manufacturing, and commercialization of silicon nitride biomaterials, composites, devices, and related technologies for medical and other applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). It also provides insulators for Tier 1 aerospace suppliers; SiNAPTIC® Foot & Ankle Osteotomy Wedge System for reconstructive surgery; OEM manufacturing of spinal implants; and SiNERGY™ technology platform for bio composite and 3D printing applications. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Exchange Ticker
LSE (United Kingdom) 0A8S.L
NMS (United States) SINT
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Jan. 25, 2016 0.07
Nov. 10, 2017 0.08
July 29, 2019 0.03
Dec. 20, 2022 1:100
May 28, 2024 1:100
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion